Page 15 - Read Online

Ishihara. Mini-invasive Surg 2021;5:36 https://dx.doi.org/10.20517/2574-1225.2021.72 Page 9 of 9

esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc 2013;78:250-7. DOI
PubMed
22. Hanaoka N, Ishihara R, Uedo N, et al. Refractory strictures despite steroid injection after esophageal endoscopic resection. Endosc Int
Open 2016;4:E354-9. DOI PubMed PMC
23. Takahashi H, Arimura Y, Okahara S, et al. A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal
stenoses after extensive endoscopic submucosal dissection. BMC Gastroenterol 2015;15:1. DOI PubMed PMC
24. Hashimoto S, Takeuchi M, Mizuno K. Prevention of stricture following semi-circular or circular esophageal ESD. Stomach Intestine
2013;48:1303-9. DOI
25. Yamaguchi N, Isomoto H, Fukuda H. Preventing stenosis after circumferential and semi-circumferential esophageal ESD -effect of
oral steroid administration. Stomach Intestine 2013;48:1291-302. DOI
26. Miwata T, Oka S, Tanaka S, et al. Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection
for superficial esophageal squamous cell carcinoma. Surg Endosc 2016;30:4049-56. DOI PubMed
27. Funakawa K, Uto H, Sasaki F, et al. Effect of endoscopic submucosal dissection for superficial esophageal neoplasms and risk factors
for postoperative stricture. Medicine (Baltimore) 2015;94:e373. DOI PubMed PMC
28. Isomoto H, Yamaguchi N, Nakayama T, et al. Management of esophageal stricture after complete circular endoscopic submucosal
dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol 2011;11:46. DOI PubMed PMC
29. Kataoka M, Anzai S, Shirasaki T, et al. Efficacy of short period, low dose oral prednisolone for the prevention of stricture after
circumferential endoscopic submucosal dissection (ESD) for esophageal cancer. Endosc Int Open 2015;3:E113-7. DOI PubMed
PMC
30. Yamaguchi N, Isomoto H, Nakayama T, et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic
submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc 2011;73:1115-21. DOI PubMed
31. Yamashina T, Ishihara R, Uedo N, et al. Safety and curative ability of endoscopic submucosal dissection for superficial esophageal
cancers at least 50 mm in diameter. Dig Endosc 2012;24:220-5. DOI PubMed
32. Matsueda K, Matsuura N, Kanesaka T, et al. Validity of endoscopic resection for clinically diagnosed T1a-MM/T1b-SM1 N0 M0
esophageal squamous cell carcinoma. Esophagus 2021;18:585-93. DOI PubMed
33. Akutsu Y, Kato K, Igaki H, et al. The prevalence of overall and initial lymph node metastases in clinical T1N0 thoracic esophageal
cancer: from the results of JCOG0502, a prospective multicenter study. Ann Surg 2016;264:1009-15. DOI PubMed
34. Mitobe J, Ikegami M, Urashima M, Takahashi H, Goda K, Tajiri H. Clinicopathological investigation of lymph node metastasis
predictors in superficial esophageal squamous cell carcinoma with a focus on evaluation of lympho-vascular invasion. Scand J
Gastroenterol 2013;48:1173-82. DOI PubMed
35. Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal
squamous cell carcinoma. Am J Gastroenterol 2013;108:544-51. DOI PubMed
36. Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for
esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006;19:475-80. DOI PubMed
37. Hatta W, Koike T, Takahashi S, et al; Tohoku GI Endoscopy Group. Risk of metastatic recurrence after endoscopic resection for
esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study. J
Gastroenterol 2021. DOI PubMed